Digbi Health Raises $5.4 Million in Series A Funding to Reverse Obesity and Associated Inflammatory Digestive and Skin Illnesses

– Digbi Health Raises $5.4 Million in Series A Funding to Reverse Obesity and Associated Inflammatory Digestive and Skin Illnesses
– Digbi Health, a leader in clinically proven genetics and gut-microbiome based digital care program for managing obesity and associated inflammatory digestive, skin and cardiometabolic illnesses, announced it has completed $5.4 million in Series A funding led by Accel, with participation from Wisdom LLP and the company’s Seed round backers Ocean Azul Partners and Seraph Venture.
– The investment brings the total funding raised by the company to $8.5 million since being founded in 2018, and will help the company to deepen its lead in evidence-based, clinically-proven and actionable science of combining genetics, the gut microbiome and clinical risk markers to deliver precision care for chronic inflammatory illnesses.